Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants.
Nat Commun. 2021 Sep 27;12(1):5652. doi: 10.1038/s41467-021-25997-3.
Nat Commun. 2021.
PMID: 34580306
Free PMC article.